Similarly, ITGB1High‐Piezo1High BLCA patients also exhibited poorer survival than ITGB1Low‐Piezo1Low patients for both progression‐free survival (PFS: hazard ratio = 5.443, p = 0.0043) and recurrence‐free survival (RFS: hazard ratio = 2.017, p = 0.0460), implying that the Piezo1/ITGB1 axis cooperated together in concert to accelerate the development and progression of BLCA (Figure 1E,F). The gene discussed is ITGB1; the disease is bladder transitional cell carcinoma.